Current Projects
Search
 

Home
Search for Projects
View Projects
Project Title
by Subject/Focus Area
by Board/Committee
by Major Unit
Provisional Committee Appointments Open for Formal Public Comments
by Last Update
Meeting Information
Conflict of Interest Policy
Committee Appointment Process
FAQ
  meetingview
More Project Information and to provide FEEDBACK on the Project

 Printer Friendly Version


Meeting Information



Project Title: Opportunities and Approaches for Supplying Molybdenum-99 and Associated Medical Isotopes to Global Markets: A Symposium

PIN: DELS-NRSB-16-03         

Major Unit:
Division on Earth and Life Studies

Sub Unit:
Nuclear and Radiation Studies Board

RSO:
Kosti, Ourania

Subject/Focus Area:
Engineering and Technology; Health and Medicine; International Issues; National Security and Defense; Policy for Science and Technology


Opportunities and Approaches for Supplying Molybdenum-99 and Associated Medical Isotopes to Global Markets: A Symposium
July 17, 2017 - July 19, 2017
International Atomic Energy Agency
Board Room A
M Building
Vienna International Centre
PO Box 100, 1400 Vienna, Austria



If you would like to attend the sessions of this meeting that are open
to the public or need more information please contact:


Contact Name: Rania Kosti
Email: okosti@nas.edu
Phone: 202 334 3066
Fax:


Agenda:

Opportunities and Approaches for Supplying Molybdenum-99 and Associated Medical Isotopes to Global Markets


Symposium Day 1: Monday, July 17, 2017

International Atomic Energy Agency
Board Room A
M Building
Vienna International Centre
PO Box 100, 1400 Vienna, Austria



9:00 Opening Session

Welcome
? Meera Venkatesh, International Atomic Energy Agency (5’)
? Christophe Xerri, International Atomic Energy Agency (5’)

Statement from the US and Russian Academies
Stepan Kalmykov, co-chair, Russian Academy of Sciences (on behalf of the symposium organizing committees) (10’)

9:20 Plenary Session
Moderator: Alexander Bychkov, Permanent Mission of the Russian Federation to the International Organizations in Vienna

Mo-99 production: past, present, and future
Hedvig Hricak, co-chair, U.S. National Academies (on behalf of the symposium organizing committees) (10’)

Russia’s role in global molybdenum-99 supply
Alexey Vakulenko, JSC V/O IZOTOP, Russian Federation (20’)

Establishing and expanding nuclear medicine programs
? Rodolfo Nunez-Miller, International Atomic Energy Agency (10’)
? Wolfgang Weber, Memorial Sloan Kettering, United States (10’)

Plenary session discussion (15’)


10:30

BREAK

10:50 Molybdenum-99 Supply Reliability: Session 1
Moderator: Jack Coffey, Enigma Biomedical Group

Organisation for Economic Co-operation and Development-Nuclear Energy Agency’s principles to address molybdneum-99 supply reliability and the organization’s global market demand and production capacity projections
Kath Smith, High-level Group on the Security of Supply of Medical Radioisotopes (15’)

The European Commission’s efforts to evaluate the supply of medical radioisotopes
Margarida Goulart, European Commission (15’)

Reactor schedule coordination for molybdenum-99 supply reliability
Bernard Ponsard, AIPES Reactors & Isotopes Working Group (15’)

Investments in AREVA’s target production facility to improve long term sustainable security of molybdneum-99 supply
Yann Guinard, AREVA, France (15’)

Session 1 discussion (20’)

12:10 Molybdenum-99 Supply: Session 2 (part 1)
Moderator: Rania Kosti, U.S. National Academies

Existing global suppliers: current production and future plans
? Roy Brown, Curium (10’)
? Michael Druce, ANSTO, Australia (10’)
? Gavin Ball, NTP, South Africa (10’)
? Jean-Michel Vanderhofstadt, IRE, Belgium (10’)


12:50

LUNCH

14:30 Molybdenum-99 Supply: Session 2 (part 2)
Moderator: Rania Kosti, U.S. National Academies

New projects for regional or global molybdenum-99 supply
? James Harvey, NorthStar, United States (10’)
? Katrina Pitas, SHINE, United States (10’)
? Carolyn Haass, Northwest Medical Isotopes, LLC, United States (10’)
? Carmen Bigles, Coquí Radio Pharmaceuticals, United States (10’)
? Matthew Lish, Flibe Energy, United States (10’)
? Hermen van der Lugt, PALLAS Reactor, Netherlands (10’)
? Oleg Kononov, Karpov Scientific Research Institute of Physics and Chemistry, Russian Federation (10’)
? Ken Buckley, TRIUMF, Canada (10’)
? Kennedy Mang’era, Canadian Isotope Innovations Corp. (10’)
? Jin Du, China Isotope & Radiation Corporation (10’)
? Anupam Mathur, Department of Atomic Energy, India (10’)
? Ul-Jae Park, Korea Atomic Energy Research Institute (10’)
? Pablo Cristini, National Atomic Energy Commission, Argentina (10’)
? Mostafa Abd Elaal, Egyptian Atomic Energy Authority (10’)


Session 2 discussion (30’)

17:30 Late afternoon break and closing remarks
(Participants move to MO2 Foyer)


19:30

Adjourn symposium day 1



Symposium Day 2: Tuesday, July 18, 2017

Location
International Atomic Energy Agency
Board Room A
M Building
Vienna International Centre
PO Box 100, 1400 Vienna, Austria


9:00 Welcome
Stepan Kalmykov, co-chair, Russian Academy of Sciences committee (on behalf of the two Academies) (5’)

9:05 Technical Considerations : Session 3
Moderator: Boris Zhuikov, Russian Academy of Sciences

Conversion to low enriched uranium-based molybdenum-99 production
? Jean-Michel Vanderhofstadt, IRE, Belgium (10’)
? Roy Brown, Curium (10’)
? Gavin Ball, NTP, South Africa (10’)
? Vladimir Risovaniy, Rosatom, Russian Federation (10’)

Production expansion
Michael Druce, ANSTO, Australia (10’)

Prospects for the use of activation of molybdenum for the production of technetium-99m generators
Victor Skuridin, Tomsk Polytechnic University, Russian Federation (15’)

High-density low enriched uranium targets production
? Bertrand Stepnik, AREVA, France (15’)
? Kinam Kim, Korea Atomic Energy Research Institute (15’)

Session 3 discussion (20’)


11:40

BREAK

12:00 Regulatory Considerations: Session 4
Moderator: Joao Alberto Osso Junior, International Atomic Energy Agency

European Medicines Agency’s regulatory considerations
Brendan Cuddy, European Medicines Agency (20’, pre-recorded)

Perspectives from Tc-99m generator manufacturers
? Ira Goldman, Lantheus Medical Imaging, United States (10’)
? Roy Brown, Curium, Netherlands (10’)

Perspectives from a nuclear pharmacy
David Pellicciarini, Cardinal Health, United States (15’)

Session 4 discussion (15’)

13:15
LUNCH


14:30 Economic Considerations: Session 5
Moderator: Charles Ferguson, Federation of American Scientists

Molybdenum-99 supply economics
Jan Willem Velthuijsen, PwC Europe (20’)

Low enriched uranium-based molybdenum-99 production
? Gavin Ball, NTP (5’)
? Michael Druce, ANSTO (5’)

Session 5 discussion (25’)


15:30

BREAK




15:50 Chemical Processing and Waste Management: Session 6
Moderator: Sergey Yudintsev, Russian Academy of Sciences

Chemical processing and waste management following neutron activation
Engeniy Nesterov, Tomsk Polytechnic University, Russian Federation (10’)

Development of a novel dry chemical uranium molybdenum separation: Research for a future efficient Mo-99 extraction process
Riane Stene, FRM-II, Germany (10’)

Waste management in HEU versus LEU-based molybdenum-99 production
Jean-Michel Vanderhofstadt, IRE, Belgium (15’)

Synroc Technology for the Management of molybdenum-99 Waste
Bruce Begg, ANSTO, Australia (10’)

Recycling processed LEU for reuse as target material
Carolyn Haass, Northwest Medical Isotopes, LLC, United States (10’)

Session 6 discussion (30’)

17:20 Closing remarks
Hedi Hricak, co-chair, US National Academies
Stepan Kalmykov, co-chair, Russian Academy of Sciences


17:30

Adjourn symposium











Invited Briefing and Tour: Wednesday, July 19, 2017

Location
International Atomic Energy Agency
TBD
Vienna International Centre (VIC)
PO Box 100, 1400 Vienna, Austria



11:30 – 12:30
IAEA activities in nuclear energy and applications
Meera Venkatesh, International Atomic Energy Agency
Christophe Xerri, International Atomic Energy Agency


12:30 – 13:10

LUNCH


13:15
Depart for IAEA laboratories in Seibersdorf*
Meeting location for departure TBD.
Arrive on time to avoid missing the bus which will depart at 13:15 promptly.
*Registration for the tour is now closed.


14:00 – 16:00

Tour of the IAEA laboratories in Seibersdorf


16:45

Return to VIC


Internet Access:

Public access WiFi is available throughout the IAEA buildings. Select access point wlan-guest and the connection will be automatic; there is no password.